AAP
GRDN icon

Arax Advisory Partners’s Guardian Pharmacy Services GRDN Stock Holding History

Arax Advisory Partners’s Portfolio GRDN Stock Details GRDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.4K Buy
+105
New +$4.07K ﹤0.01% 4632
2026
Q1 		– Sell
-1
Closed -$30 – 4435
2025
Q4 		$30 Sell
1
-99
-99% -$2.8K ﹤0.01% 3995
2025
Q3 		$2.62K Buy
+100
New +$2.38K ﹤0.01% 3046

Other funds holding GRDN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
VCM
Valiant Capital Management San Francisco, California $2.48B AUM 57.08% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

Arax Advisory Partners's GRDN Position: Q2 2026 in Review

Arax Advisory Partners opened a new position in Guardian Pharmacy Services (GRDN) in Q2 2026: 105 shares worth $4.4K. The stake represents ﹤0.01% of the portfolio and ranks #4632 among its holdings. This is a return to the name: Arax Advisory Partners previously reported a position in GRDN as recently as Q4 2025.

Arax Advisory Partners first reported a position in GRDN in Q3 2025 and has held it in 3 quarters since. 190 funds tracked by Wall St. Rank hold GRDN as of Q2 2026.

  • Arax Advisory Partners held 105 shares of Guardian Pharmacy Services worth $4.4K as of Q2 2026.
  • Guardian Pharmacy Services was a new Arax Advisory Partners position in Q2 2026.
  • Guardian Pharmacy Services made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #4632 holding.
  • Arax Advisory Partners first reported a position in Guardian Pharmacy Services in Q3 2025 and has held it in 3 quarters since.
  • 190 funds tracked by Wall St. Rank held Guardian Pharmacy Services as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.